PRKG2 and osteoporosis: We previously showed that pharmacological PKG activation, or osteoblast-specific expression of a partly activated PKG2 (PKG2R242Q), protects mice against osteoporosis caused by type 1 diabetes by improving bone formation and preventing osteocyte apoptosis (14, 15).